We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Manufacturing, Apple, & Jobs: This Week's Top Market Stories
Read MoreHide Full Article
On today’s episode of the Zacks Friday Finish Line, Associate Stock Strategist Ryan McQueeney and Editor Maddy Johnson discuss the ISM manufacturing index, the latest jobs report, Apple’s profit warning, and a major merger deal in the biotech industry.
Make sure to subscribe and leave the show a rating on Apple Podcasts!
Stocks gained in early trading Friday, erasing much of the losses witnessed Thursday on the back of a reassuring jobs report. The U.S. economy added 312,000 jobs last month, crushing expectations and cooling fears of a slowdown.
The jobs report also revealed that average hourly earnings were up 3.2% from last year and that the labor force participation rate had surged to a five-year high. These positives were delivered just one day after Wall Street raised serious questions about the domestic economy thanks to another key macroeconomic indicator.
Indeed, the latest data from the ISM manufacturing index caused volatility Thursday. The measure of U.S. manufacturing activity showed growth had slowed to its slowest pace in two years, with sluggish demand for new products creating a tepid atmosphere in the industry.
Investors earlier this week were also troubled by news from tech behemoth Apple (AAPL - Free Report) . The iPhone maker issued its first profit warning in over 15 years on Wednesday, citing weakness in Greater China as the key reason for its disappointing quarter. Apple’s note of caution spooked investors and underscored concerns about the effects of the trade war.
Nevertheless, a separate industry saw bullish sentiment on Thursday. That industry was biotech, as several stocks surged into the green thanks to residual excitement stemming from Bristol Meyers Squibb’s (BMY - Free Report) deal to buy cancer-treatment specialist Celgene .
Will other biotechs find themselves the targets of takeover chatter this year? Was Apple’s guidance cut actually a big deal? How should investors feel about this week’s mixed macroeconomic news? Ryan and Maddy answer these questions, and more, only on the Zacks Friday Finish Line!
If you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on Apple Podcasts.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Manufacturing, Apple, & Jobs: This Week's Top Market Stories
On today’s episode of the Zacks Friday Finish Line, Associate Stock Strategist Ryan McQueeney and Editor Maddy Johnson discuss the ISM manufacturing index, the latest jobs report, Apple’s profit warning, and a major merger deal in the biotech industry.
Make sure to subscribe and leave the show a rating on Apple Podcasts!
Stocks gained in early trading Friday, erasing much of the losses witnessed Thursday on the back of a reassuring jobs report. The U.S. economy added 312,000 jobs last month, crushing expectations and cooling fears of a slowdown.
The jobs report also revealed that average hourly earnings were up 3.2% from last year and that the labor force participation rate had surged to a five-year high. These positives were delivered just one day after Wall Street raised serious questions about the domestic economy thanks to another key macroeconomic indicator.
Indeed, the latest data from the ISM manufacturing index caused volatility Thursday. The measure of U.S. manufacturing activity showed growth had slowed to its slowest pace in two years, with sluggish demand for new products creating a tepid atmosphere in the industry.
Investors earlier this week were also troubled by news from tech behemoth Apple (AAPL - Free Report) . The iPhone maker issued its first profit warning in over 15 years on Wednesday, citing weakness in Greater China as the key reason for its disappointing quarter. Apple’s note of caution spooked investors and underscored concerns about the effects of the trade war.
Nevertheless, a separate industry saw bullish sentiment on Thursday. That industry was biotech, as several stocks surged into the green thanks to residual excitement stemming from Bristol Meyers Squibb’s (BMY - Free Report) deal to buy cancer-treatment specialist Celgene .
Will other biotechs find themselves the targets of takeover chatter this year? Was Apple’s guidance cut actually a big deal? How should investors feel about this week’s mixed macroeconomic news? Ryan and Maddy answer these questions, and more, only on the Zacks Friday Finish Line!
If you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on Apple Podcasts.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>